Table 2.
Demographic and clinical characteristics of the 32 human immunodeficiency virus (HIV)-positive participants of the study.
| Characteristic | N |
|---|---|
| Males (%) | 24 (75%) |
| Age (years) (mean ± SD) | 40 ± 12.3 |
| Median baseline CD4+ T-cell counts (cells/mm3; IQR50) | 712.5 (606.5–856) |
| Median baseline CD8+ T-cell counts (cells/mm3; IQR50) | 657.5 (529–1047.25) |
| Median time since HIV diagnosis (years; IQR50) | 4.7 (3.9–6.5) |
| Median time from HIV diagnosis to antiretroviral therapy initiation (years; IQR50) * | 1.2 (0.6–2.8) |
| Median time of treatment (years; IQR50) | 3.1 (2.4–3.9) |
* Missing in one patient; SD, standard deviation; IQR50, interquartile range.